News Industry News Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial September 27, 2019
News Industry News Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial October 27, 2015